ISOPP 2025 Dispatch – Day 1: BiTEs, B-ALL, CSTDs & ADCs

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/0e/cb/3a/0ecb3a30-1d24-f8be-559b-4b8344f48dfa/mza_2783373006037170972.jpg/600x600bb.jpg

Irish Haematology Oncology Podcast

Eoin Tabb

20 episodes

4 days ago

The Irish Haematology Oncology Podcast is your friendly, jargon-free guide to the world of cancer care. Perfect for doctors, nurses, pharmacists, and anyone interested in simplifying this complex field.

Education

RSS

All content for Irish Haematology Oncology Podcast is the property of Eoin Tabb and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Education

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/40762625/40762625-1714309459550-85ef57619c51b.jpg

ISOPP 2025 Dispatch – Day 1: BiTEs, B-ALL, CSTDs & ADCs

Irish Haematology Oncology Podcast

20 minutes 11 seconds

7 months ago

ISOPP 2025 Dispatch – Day 1: BiTEs, B-ALL, CSTDs & ADCs

Join host Eoin Tabb for a special dispatch episode recorded live from the ISOPP 2025 Symposium in Victoria, BC. Get your 'audio delegate bag' with key insights from Day 1, covering:

Implementing bispecific antibodies (BiTEs) like teclistamab and talquetamab in multiple myeloma, focusing on community administration and managing toxicities (CRS, ICANS, infections, oral/skin/nail issues).
The practice-changing impact of blinatumomab in frontline B-ALL based on the E1910 trial.
Innovations in hazardous drug safety using Closed System Transfer Devices (CSTDs) and automation.
SMART strategies for managing toxicities (ILD, neutropenia, nausea, neuropathy) of ADCs like T-DXd, T-DM1, and Sacituzumab Govitecan in metastatic breast cancer.